• Nexstim received an order for an NBS 6 system from an existing hospital customer in Europe.
• System will be used mainly for pre-surgical brain mapping, with potential expansion into therapy applications later.
• NBS 6 is CE-marked in Europe for brain mapping, major depressive disorder, chronic neuropathic pain, and post-operative upper-limb rehabilitation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nexstim Oyj published the original content used to generate this news brief on September 01, 2026, and is solely responsible for the information contained therein.